2013 was a good year for public medtech companies. This chart shows why.
So how did CEOs fare last year? When it comes to annual compensation, who comprises the medtech world's 1%?
We researched MD+DI's Top 40 Medical Device Companies, including only U.S-based medtech companies, and then scoured data from FindtheBest and, in some cases, company proxy statements to come up with the list of 15 highest-paid medtech CEOs in the country.
The results are interesting because in many cases CEOs of firms such as Danaher that have more than a billion in revenue from medtech but pull in much more from other industry segments ended up ranking higher on the list with a larger compensation than CEOs of pure-play device firms like Medtronic. And then, not surprisingly, CEOs of diversified firms like General Electric and Johnson & Johnson also did better than other medtech CEOs.
Without further ado, here are the top 15 highest-paid medtech CEOs in the U.S, starting with no.15 on the list. Drumroll please...
[Photo Adapted from a Wall Street Journal YouTube Video]
In 2013, Lobo made $8.4 million, which brought his compensation down 8.6% from the previous year.
[Feature Image Credit: iStockphoto.com user thorbjorn66]